Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Artificial Intelligence utilization, perceptions, and readiness within the infection prevention workforce: Findings from the 2025 APIC MegaSurvey.

Created on 25 Aug 2026

Authors

Shelley E Kon, Janet Haas, Bryan Knepper, Monika Pogorzelska-Maziarz, Sara M Reese, 2025 APIC MegaSurvey Task Force

Published in

American journal of infection control. Aug 24, 2026. Epub Aug 24, 2026.

Abstract

The advent of artificial intelligence (AI) presents an opportunity to enhance infection prevention practices. However, its use among infection preventionists (IP) remains unknown.
We analyzed responses from IPs participating in the 2025 APIC MegaSurvey to assess (1) current utilization of AI (2) familiarity and perceived usefulness of AI, (3) organizational readiness, (4) barriers and (5) training and support needs.
A total of 4,269 IPs participated in the survey, of whom 3,220 participants responded to the AI section. Among respondents, 12.6% (n=404) reported using AI. Of those that use AI, 65.7% (n=266) used generative AI tools such as ChatGPT to draft policies, educational content, or to synthesize research followed by AI-powered chatbots to support triage or deliver staff education (35.6%, n=144), risk stratification (32.8%, n=133) and predictive modeling (21.7%, n=88). Most respondents perceived AI as useful (80%, n=2657) and were interested in learning more (n=2413, 74.9%). Lack of organizational readiness, limited access, concerns about accuracy, data privacy and job displacement were among barriers identified.
AI use among IPs remains low, despite interest and perceived value. There remain concerns about accuracy, data privacy, and job displacement.
Findings highlight a gap between interest in AI and its integration into IP practice. Efforts to improve training, access, and organizational readiness will be essential to support safe and effective adoption.

PMID:
42637045
Bibliographic data and abstract were imported from PubMed on 25 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 17
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement